转染试剂
- 名transfection reagent
-
该试验设立两个对照组:空白对照(未加siRNA及转染试剂)及阴性对照组(只加转染试剂,无siRNA)。
The study consisted of two control groups ; blank control group treated with neither siRNA nor transfection reagent and negative control group treated only with transfection reagent .
-
D组:予空白质粒转染试剂瘤内注射,每日一次。
Group D : blank plasmid transfection reagent intratumoral injection once a day .
-
结果①脂质体转染试剂对悬浮培养的k562细胞转染效率较低。
Result The efficiency of liposomal reagent was low for suspended k562 cells .
-
结果单纯损伤组和Lipofectin转染试剂组7d时可见内膜明显增生,且有较多平滑肌细胞表达PCNA,CFos30min表达达高峰。
Results There was significant intimal hyperplasia and obvious PCNA expression of smooth muscle cells at 7 day in Lipofectin group and only injury group , the expression of c-fos reached peak at 30 minutes .
-
对重组质粒进行双酶切、PCR和测序验证后,采用融细胞膜类基因转染试剂Trans-EZ将重组质粒转染至APOE敲除鼠星形胶质细胞,并利用划痕致伤建立细胞损伤模型。
Recombinant plasmid was identified by enzyme digestion , PCR and sequence analysis . Recombinant plasmid was transfected into APOE knocked out astrocytes with Trans-EZ and an in vitro trauma model was produced by scratch injury .
-
结果表明:相同用量的两种转染试剂对293细胞、PK细胞和MDCK细胞的生长的影响远远小于对CEF细胞的影响;
The results showed that the growth of the CEF cells were greater effected than that of 293 cells 、 PK cells and MDCK cells when the same dosages of the two kinds of transfection reagents were used .
-
病毒感染BHK21细胞后,通过阳离子转染试剂将重组质粒导入感染细胞,在此基础上评价融合蛋白D2C-SN抗登革病毒感染的治疗效果。
The recombinant plasmids were then transfected into BHK-21 cells pre-infected with wild dengue 2 virus , and the effect on dengue virus multiplication was evaluated by examining the production of infectious virions .
-
新一代阳离子聚合物转染试剂(梭华-Sofast)转染效果研究
Study on the Transfection Efficiency of the New Cationic Polymer Transfection Reagent : Sofast
-
细胞转染试剂盒
Reagents for cell transfection
-
毒性实验结果显示这种复合物的毒性比商业化的脂质体转染试剂小。
Toxicity test showed that the toxicity of these complexes was lower than that of the commercial liposome reagent .
-
该段siRNA转染的毒性作用主要来自于转染试剂,与序列本身无明确关系。
The toxic effect of siRNA transfection principally comes from the transfection reagent .